Updated Use Of First-Line Chemotherapy For Advanced Pancreatic Cancer: Folfirinox Versus Gemcitabine

Thomas H. Cartwright, Aimee Ginsburg Arlen,Lalan S. Wilfong,Robyn K. Harrell,J. Russell Hoverman,Roy A. Beveridge

Journal of Clinical Oncology（2013）

引用 23|浏览19

暂无评分

摘要

6607 Background: Pancreatic cancer (PC) is the fourth leading cause of death in the United States. It is estimated that 45,220 patients will be diagnosed in 2013 and 38,460 will die (Siegel, CA Can...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要